Quince Therapeutics

QNCX

Market cap $119M

2.14 USD

+0.10

4.9%

At close Updated Nov 21, 4:00 PM EST

Pre-market

After hours

2.14

0.00

1 day

4.9%

5 days

27.38%

1 month

17.58%

3 months

32.92%

6 months

107.77%

Year to date

13.83%

1 year

2.88%

5 years

-96.05%

10 years

-93.49%

About: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Employees: 36

Healthcare Biotechnology